About TrovaGene, Inc.

Trovagene, Inc. is a clinical-stage, precision cancer medicine oncology therapeutics company, which engages in the development of drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, lymphomas, and solid tumors. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan on August 4, 1999 and is headquartered in San Diego, CA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -1.85$ per share.

The book value per share is 0.98$

TrovaGene, Inc. website

Create a solid portfolio with TROV

Add TROV to your portfolio and optimize it!


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- -102.10% -16M - -15M -1.85 - - 9M 0.98 -13M - -13M